Literature DB >> 10734064

Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-) deficiency.

F Gómez-Gallego1, A Garrido-Pertierra, J M Bautista.   

Abstract

The enzyme variant glucose-6-phosphate dehydrogenase (G6PD) A(-), which gives rise to human glucose-6-phosphate dehydrogenase deficiency, is a protein of markedly reduced structural stability. This variant differs from the normal enzyme, G6PD B, in two amino acid substitutions. A further nondeficient variant, G6PD A, bears only one of these two mutations and is structurally stable. In this study, the synergistic structural defect in recombinant G6PD A(-) was reflected by reduced unfolding enthalpy due to loss of beta-sheet and alpha-helix interactions where both mutations are found. This was accompanied by changes in inner spatial distances between residues in the coenzyme domain and the partial disruption of tertiary structure with no significant loss of secondary structure. However, the secondary structure of G6PD A(-) was qualitatively affected by an increase in beta-sheets substituting beta-turns related to the lower unfolding enthalpy. The structural changes observed did not affect the active site of the mutant proteins, since its spatial position was unmodified. The final result is a loss of folding determinants leading to a protein with decreased intracellular stability. This is suggested as the cause of the enzyme deficiency in the red blood cell, which is unable to perform de novo protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734064     DOI: 10.1074/jbc.275.13.9256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.

Authors:  Anna D Cunningham; Sunhee Hwang; Daria Mochly-Rosen
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

2.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

3.  High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.

Authors:  Eugene Sobngwi; Jean-François Gautier; Jean-Philippe Kevorkian; Jean-Marie Villette; Jean-Pierre Riveline; Sumei Zhang; Patrick Vexiau; Suzanne M Leal; Christian Vaisse; Franck Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

4.  Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield.

Authors:  Saúl Gómez-Manzo; Jessica Terrón-Hernández; Ignacio de la Mora-de la Mora; Itzhel García-Torres; Gabriel López-Velázquez; Horacio Reyes-Vivas; Jesús Oria-Hernández
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

5.  Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: Decreased stability and catalytic efficiency contribute to the clinical phenotype.

Authors:  Usa Boonyuen; Kamonwan Chamchoy; Thitiluck Swangsri; Naowarat Saralamba; Nicholas P J Day; Mallika Imwong
Journal:  Mol Genet Metab       Date:  2016-03-25       Impact factor: 4.797

6.  Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency.

Authors:  Phonchanan Pakparnich; Sirapapha Sudsumrit; Mallika Imwong; Teeraporn Suteewong; Kamonwan Chamchoy; Danaya Pakotiprapha; Ubolsree Leartsakulpanich; Usa Boonyuen
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

7.  An optimised system for refolding of human glucose 6-phosphate dehydrogenase.

Authors:  Xiao-Tao Wang; Paul C Engel
Journal:  BMC Biotechnol       Date:  2009-03-11       Impact factor: 2.563

8.  Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.

Authors:  Sunhee Hwang; Karen Mruk; Simin Rahighi; Andrew G Raub; Che-Hong Chen; Lisa E Dorn; Naoki Horikoshi; Soichi Wakatsuki; James K Chen; Daria Mochly-Rosen
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.